ERBB2 and breast cancer: GCDFP-15 is expressed in all major biological breast cancer subtypes, and may be particularly useful as a diagnostic marker for mammary differentiation in HR and HER2 positive tumors, while there is reduced sensitivity in the triple negative subset.